Chapter 1

Pasture-Raised at Scale

Vital Farms sells premium pasture-raised eggs and butter sourced from a contracted network of more than 600 small farms, and has grown net revenue from $141 million in 2019 to $759 million in 2025 while turning a near-zero operating margin into 11.6%. The stock tells a different story: after peaking above $52 in August 2025 it trades near $13, roughly 75% lower, as a heavy capacity-building cycle pushes 2026 toward reported losses. This chapter establishes what the business is, how it earns, and the question the rest of the report answers.

What the company is

Vital Farms is a branded consumer-staples company built around a single differentiated claim: eggs and butter from animals raised on pasture, sourced through a "distributed supply chain of small farms" rather than industrial cages or barns [1]. It was founded in 2007 on a 27-acre plot in Austin, Texas, sold its first eggs at farmers markets, and was picked up by Whole Foods within a year [2]. It is a Delaware public benefit corporation and a Certified B Corporation — a legal structure that binds management to stakeholders beyond shareholders, and a governance fact worth carrying forward for a value investor [3].

The model is asset-light at the hen and asset-heavy at the plant. Vital Farms does not own most of the farms; it contracts with a network of more than 600 family farms that raise the birds, and concentrates its own capital in processing — a shell-egg washing and grading facility called Egg Central Station in Springfield, Missouri [4]. In 2024 it began adding company-owned "accelerator farms" to test practices at scale, and it began placing birds on them in 2025 [5].

By its own measure, the brand leads its niche: Vital Farms reports it is the #1 U.S. pasture-raised egg brand, #1 in the natural channel, and #2 U.S. egg brand overall by retail dollar sales [6]. It competes with commodity egg producers such as Cal-Maine Foods, international brands such as Ornua's Kerrygold in butter, and — increasingly — private-label pasture-raised eggs [7].

How the economics have moved

The growth record is the clearest fact in the file. Revenue compounded at roughly 32% a year over six years, and gross profit rose in step.

Source: FY2025 Annual Report (Form 10-K), five-year performance graphic and Consolidated Statements of Operations [8].

Profitability is a more recent development. Operating margin was effectively zero through 2021–2022 — the company earned $2 million of operating income on $362 million of revenue in 2022 — before recovering to 11.6% in 2025. The swing reflects operating leverage over a plant-heavy cost base and firmer pricing, not a change in what the company sells.

Source: derived from reported financials, FY2019–FY2025 10-Ks; income from operations per FY2025 Annual Report (Form 10-K), Consolidated Statements of Income [9].

Source: FY2025 Annual Report (Form 10-K), Consolidated Statements of Income [10].

One structural point sits underneath the growth. The company's own history graphic shows store count essentially flat — about 24,000 retail locations across 2023, 2024 and 2025 — even as revenue rose from $472 million to $759 million over the same span [11]. Recent growth has come from selling more through the same shelves — deeper household penetration, more units per store, higher price — rather than from new doors. Whether that velocity persists is a question a later chapter takes up.

The stock: a round trip

For a reader meeting the name now, the share price is the first puzzle. Vital Farms came public in July 2020 near $35, fell to roughly $8 in 2022, then ran to an intraday high above $52 in August 2025 before collapsing back toward $13 by mid-2026 — a full round trip that left the stock about 75% below its 2025 peak even though revenue and profit kept rising.

Source: company share price history, as reported (2026 shown through July 10, 2026).

The gap between a business tripling in size and a stock cut to a quarter of its peak is the tension the report exists to resolve. At about $13, the shares carry a market value near $596 million against $66 million of 2025 net income — roughly 9 times trailing earnings — for a company that grew revenue 25% last year.

Source: share price and shares outstanding, as reported; trailing diluted EPS of $1.44 from FY2025 Annual Report (Form 10-K), Consolidated Statements of Income [12].

Why the market turned: the investment cycle

The re-rating coincides with a deliberate shift into a heavy spending phase. Capital expenditure jumped to about $82 million in 2025 as the company built out capacity, and free cash flow — reliably positive in 2023 and 2024 — swung to roughly negative $48 million. Vital Farms broke ground in 2025 on Vital Crossroads, a second washing-and-packing facility in Seymour, Indiana, that it expects to be fully operational in 2027 [13].

Source: derived from reported financials, FY2020–FY2025 Consolidated Statements of Cash Flows [14].

Management has framed this as a phase, not a new normal. In December 2025 it set a target of $2 billion in net revenue by 2030 with 15% to 17% adjusted EBITDA margins and gross margins above 35%, and guided initial 2026 net revenue to $930–950 million — continued growth of roughly a quarter [15] — while describing 2026 as a transition "from capacity building to market expansion" [16]. The near-term cost of that transition is real: the company itself warns that rising operating and capital expenses may prevent it from maintaining or increasing profitability, and consensus now expects Vital Farms to report losses through 2026 even as revenue climbs [17]. That is the shape of a "worse before better" year rather than a broken business — but the burden of proof is on execution.

The balance sheet and the governance flag

For a reader who screens out anything that could go bankrupt, the balance sheet is reassuring. Vital Farms funds this cycle from cash and a $60 million revolving credit facility that carries no drawn term debt, secured on substantially all its assets and undrawn as a backstop [18]. With shareholders' equity of $351 million and no meaningful leverage, near-term solvency is not the risk; execution and returns on the new plants are.

Governance carries a fresh complication. Founder Matthew O'Hayer — the largest holder, whose stake has fallen from about 27% at the IPO toward 16% — resigned as Executive Chairperson, board member, and employee effective February 24, 2026, and the board handed the combined Executive Chairperson, President and CEO roles to Russell Diez-Canseco [19]. A founder's departure and a combined chair/CEO are exactly the governance details this reader weighs, and they warrant a chapter of their own.

The question this report answers

Vital Farms is a genuine category leader trading like a broken one, in the middle of a self-inflicted investment year. The question the rest of this report exists to answer is whether Vital Farms can convert its lead in pasture-raised eggs — a brand-and-farmer-network model that has compounded revenue near 30% a year and finally earned double-digit operating margins — into durable, consistent free cash flow on the path to its $2 billion-by-2030 ambition, or whether a premium egg brand remains hostage to commodity feed and egg-price swings, avian-influenza supply shocks, and the private-label competition now entering the category it created. Each chapter that follows tests one part of that question against the filings.